Evidence map›Paper›PMID 41673015›Full record

ArticleNature communications2026

Genome-wide discovery and phenotyping of non-coding transcripts in A. fumigatus reveals lncRNAs with a role in antifungal drug sensitivity.

Danielle Weaver, Tanda Qi, Harry Chown, Marcin Fraczek, Ressa Lebedinec, Lauren Dineen, Clara Valero, Norman van Rhijn, Takanori Furukawa, Michael Bromley and 2 more

Abstract readDataset
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. A long non-coding RNA,mSphere · 2026
    Article
  4. Thermal adaptation crosstalk with azole response through lncRNA inbioRxiv : the preprint server for biology · 2026
    Article
  5. A long non-coding RNA,bioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Azole-ResistantJournal of fungi (Basel, Switzerland) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Danielle Weaver *Division of Infection, Immunity & Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Tanda Qi *Manchester Institute of Biotechnology, The University of Manchester, Manchester, UK.ORCID http://orcid.org/0000-0002-2097-246X
Harry Chown *Division of Evolution, Infection & Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.ORCID http://orcid.org/0000-0002-5331-4711
Marcin FraczekManchester Institute of Biotechnology, The University of Manchester, Manchester, UK.
Ressa LebedinecDivision of Evolution, Infection & Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Lauren DineenDivision of Evolution, Infection & Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Clara ValeroDivision of Evolution, Infection & Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Norman van RhijnDivision of Evolution, Infection & Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.ORCID http://orcid.org/0000-0001-6722-2757
Takanori FurukawaDivision of Evolution, Infection & Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.ORCID http://orcid.org/0000-0001-9385-9612
Michael BromleyDivision of Evolution, Infection & Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. mike.bromley@manchester.ac.uk.ORCID http://orcid.org/0000-0002-7611-0201
Daniela DelneriManchester Institute of Biotechnology, The University of Manchester, Manchester, UK. d.delneri@manchester.ac.uk.
Paul BowyerDivision of Evolution, Infection & Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. paul.bowyer@manchester.ac.uk.ORCID http://orcid.org/0000-0002-1083-9286

Funding

Wellcome Trust (Wellcome) 208396/Z/17/Z
6 · The paper itself

Abstract

Recent data suggests one fungus, Aspergillus fumigatus, causes more deaths annually than HIV or malaria combined. Coupled with rapid emergence of antifungal drug resistance, the limited range of effective treatments, and mortality rates of >50%, aspergillosis represents a major challenge in infectious diseases. Recent studies have identified long-noncoding RNAs (lncRNAs) involved in drug resistance and virulence in pathogenic yeasts such as Candida spp. However, there is very limited knowledge of lncRNAs in human pathogenic moulds, including A. fumigatus. Here we exploit transcriptomics data of A. fumigatus exposed to different environments to annotate transcripts mapping to 2388 genomic loci. After manual curation we generate a database of over 1000 lncRNAs. We observe that the lncRNAs display orchestrated transcriptional profiles upon drug treatment and many are proximal to genes involved in azole sensitivity. We knock out a set of intergenic lncRNAs and perform a large-scale phenotypic analysis to identify 60 lncRNA mutants displaying condition-dependent fitness changes with 35 mutants exhibiting a positive growth phenotype under azole stress. Overall, this study generates and experimentally validates an important resource that will enable the wider research community to increase understanding of the functional importance of lncRNAs in A. fumigatus, including their involvement in drug sensitivity.

Indexed as

Antifungal AgentsAspergillus fumigatusAzolesDrug Resistance, FungalRNA, FungalRNA, Long NoncodingGene Expression Regulation, FungalGenome, FungalHumansAntifungal AgentsAzolesRNA, FungalRNA, Long Noncoding

Identifiers

PMID41673015
PMCPMC12921299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.